Core Viewpoint - The stock of Blue Biological (603739) experienced a significant increase of 6.93% with a trading volume of 877 million yuan and a turnover rate of 22.20% on the day, despite a net sell-off by institutional investors totaling 41.34 million yuan [2]. Trading Activity - The stock's turnover rate reached 22.20%, leading to its listing on the exchange's watchlist, with a total net sell-off of 41.34 million yuan by institutional investors [2]. - The top five trading departments accounted for a total transaction volume of 143 million yuan, with a buying amount of 50.88 million yuan and a selling amount of 92.22 million yuan, resulting in a net sell-off of 41.34 million yuan [2]. - The largest buying department was Dongfang Caifu Securities, which purchased 11.87 million yuan, while the largest selling department was Kaiyuan Securities, which sold 43.84 million yuan [2]. Fund Flow - The stock saw a net outflow of 30.26 million yuan from main funds, with a significant inflow of 10.43 million yuan from large orders, while large orders experienced a net outflow of 40.70 million yuan [2]. - Over the past five days, the main funds have seen a net inflow of 108 million yuan [2]. Financial Performance - According to the third-quarter report released on October 29, 2024, the company achieved a total revenue of 946 million yuan for the first three quarters, reflecting a year-on-year growth of 7.50%. However, the net profit was reported at 40.85 million yuan, indicating a year-on-year decline of 26.17% [2].
蔚蓝生物龙虎榜:营业部净卖出4134.13万元